Did anyone listen to the conference call. I'm trying to reconcile the following statement with the quarterly cashflow
Burnt through a touch over $5m in the Dec quarter. Closer to $7m in a normal quarter without the R&D rebate. Saying they have 2.8 quarters of cash at that rate.
Can't see any fixed interest instruments or finance arrangements like EBR. R&D virtually nothing and smallish product manufacturing cost, so not a lot a lot to take out.
Would have to be some drastic cuts in expenses or a huge lift in sales.
Can anyone comment on how they have sufficient capital to get them through to Aug 2025 without a capital raising?
Thanks in advance
- Forums
- ASX - By Stock
- CVB
- Ann: Quarterly Activities/Appendix 4C Cash Flow Report
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-2
-
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CVB (ASX) to my watchlist
(20min delay)
|
|||||
Last
11.0¢ |
Change
0.010(10.0%) |
Mkt cap ! $34.93M |
Open | High | Low | Value | Volume |
11.0¢ | 11.0¢ | 11.0¢ | $22.63K | 205.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 200000 | 10.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
11.0¢ | 40026 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 200000 | 0.105 |
4 | 118584 | 0.100 |
2 | 18594 | 0.098 |
3 | 231505 | 0.095 |
1 | 24829 | 0.092 |
Price($) | Vol. | No. |
---|---|---|
0.110 | 40026 | 1 |
0.115 | 28933 | 1 |
0.120 | 20000 | 1 |
0.125 | 18181 | 1 |
0.130 | 26667 | 1 |
Last trade - 11.17am 12/11/2024 (20 minute delay) ? |
Featured News
CVB (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online